The ACME Laboratories Ltd.

ACMELAB

BD0491ACME00

Pharmaceuticals

End-of-day quote Dhaka S.E. Other stock markets 06:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
67.1 ^BDT	-0.74%		-4.01%	-21.06%

May. 12	The ACME Laboratories Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
Jan. 15	The ACME Laboratories Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

The ACME Laboratories Ltd. Obtains Certificate of GMP Compliance from UK MHRA

March 11, 2019 at 08:35 am EDT

The ACME Laboratories Ltd. announced that they have received the certificate of GMP Compliance from UK MHRA (Medicines and Healthcare Products Regulatory Agency of UK) following successful inspection of its Solid Dosage Unit (SDU) at Dhulivita, Dhamrai, Dhaka -1350, Bangladesh. This success will open the doors for the company to enter UK and other European Markets.

Latest news about The ACME Laboratories Ltd.

The ACME Laboratories Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	May. 12	CI
The ACME Laboratories Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Jan. 14	CI
The ACME Laboratories Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 14	CI
The ACME Laboratories Ltd. Recommends Cash Dividend for the Year Ended June 30, 2023	23-10-29	CI
The ACME Laboratories Ltd. Appoints Masudur Rahman Bhuyian as Company Secretary	23-10-29	CI
The ACME Laboratories Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-15	CI
The ACME Laboratories Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-15	CI
The ACME Laboratories Ltd. Announces US FDA approval for "Chlorzoxazone tablet" of the Company	23-05-02	CI
The ACME Laboratories Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-01-29	CI
The ACME Laboratories Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-23	CI
The ACME Laboratories Ltd. Recommends Cash Dividend for the Year Ended June 30, 2022	22-10-27	CI
The ACME Laboratories Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	22-05-24	CI
The ACME Laboratories Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	22-02-02	CI
The ACME Laboratories Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2021	21-11-11	CI
The ACME Laboratories Ltd. Recommends Cash Dividend for the Year Ended on June 30, 2021	21-10-27	CI
The Acme Laboratories Ltd. Reports Earnings Results for the Third Quarter Ended March 31, 2021	21-04-28	CI
The Acme Laboratories Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2020	20-11-12	CI
The Acme Laboratories Ltd. Recommends Cash Dividend for the Year Ended June 30, 2020	20-10-15	CI
The ACME Laboratories Ltd. Announces Launching of Zolpidem Tablet in the US Market	20-10-15	CI
The Acme Laboratories Ltd. Reports Earnings Results for the Third Quarter Ended March 31, 2020	20-06-07	CI
The Acme Laboratories Ltd. Reports Earnings Results for the Second Quarter Ended December 31, 2019	20-01-29	CI
The Acme Laboratories Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2019	19-10-29	CI
The ACME Laboratories Ltd. Recommends Cash Dividend for the Year Ended June 30, 2019	19-10-10	CI
The ACME Laboratories Ltd. Declares Commencement of Commercial Production of the Penicillin Facility	19-06-13	CI
Acme Laboratories Ltd. Reports Earnings Results for the Third Quarter Ended March 31, 2019	19-04-29	CI

Chart The ACME Laboratories Ltd.

Duration

Period

More charts

Company Profile

The ACME Laboratories Limited is a Bangladesh-based company, which is engaged in manufacturing, marketing, and distribution of pharmaceuticals formulation products. The Company is engaged in manufacturing, marketing, and distribution of generic pharmaceuticals formulation products which includes human drugs comprising dosages form like a tablet, capsule, dry syrup, cream, ointment, powder, injection, dry powder inhaler, metered dosage inhaler, suppository, eye and nasal drop, liquid, liquid in hard gelatine, Blow Fill Seal (BFS) products and sachet products. It also offers veterinary drugs comprising dosages form like bolus, liquid, injection, water-soluble powder, premix, and herbal drugs comprising dosages form like liquid, capsule, tablet and cream and ointment. The products of the Company are sold in domestic and international markets respectively. Its factory is situated at Dhulivita, Dhamrai, Dhaka, Bangladesh. It produces approximately 800 products in different dosage forms.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
THE ACME LABORATORIES LTD.	-21.06%	122M
ELI LILLY AND COMPANY	+37.78%	705B
NOVO NORDISK A/S	+32.82%	583B
JOHNSON & JOHNSON	-3.51%	364B
MERCK & CO., INC.	+19.94%	332B
ABBVIE INC.	+5.14%	291B
ASTRAZENECA PLC	+16.64%	238B
ROCHE HOLDING AG	-4.13%	210B
NOVARTIS AG	+10.63%	209B
AMGEN INC.	+9.32%	169B

Other Pharmaceuticals